Waystar, which makes healthcare revenue cycle management software, buys Patientco, which provides patient billing and payments software, sources say for $450M+
Context & Ripple Effects
This deal sits inside Waystar's private-equity ownership arc: EQT and Canada's pension fund took a majority stake in Waystar at a $2.7B valuation in 2019, and buying Patientco extends the revenue cycle management vendor downstream from providers' back offices into patient-facing billing and payments — a more consumer-like experience per the reported rationale.
The move also previews a consolidation wave in medical billing software: months later, Kareo merged with PatientPop to form Tebra, which then raised $72M+ at a $1B+ valuation in 2022. Waystar's own path validated the strategy, exiting via an IPO that raised $968M at a ~$3.6B market value in 2024.
First-order effects
- Waystar folds Patientco's patient billing and payments software onto its provider-side revenue cycle platform, letting hospitals and health systems offer one consumer-style payment experience instead of stitching vendors together.
- Patientco exits as an independent company, its investors reportedly clearing a $450M+ sale under Waystar's PE owners.
Second-order effects
- Rivals bundling records and billing — like Kareo and PatientPop, whose merger created Tebra — face pressure to match the combined RCM-plus-patient-payments stack or concede the enterprise account to Waystar.
- The premium on payments capability pushes other revenue cycle software vendors toward acquisitions rather than building patient-payment rails themselves.
Third-order effects
- If the pattern holds, healthcare revenue cycle management consolidates into a few full-stack platforms spanning claims processing through patient checkout, with scale in payments data becoming the durable moat — and with PE-backed rollups using such deals to position portfolio companies for public exits, as Waystar's 2024 IPO later showed.
The trend: Healthcare back-office software is consolidating around end-to-end platforms that connect provider revenue cycles directly to patient payments, with private equity assembling the stacks ahead of public listings.